Encompass Health
333 hedge funds and large institutions have $4.51B invested in Encompass Health in 2017 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 138 increasing their positions, 112 reducing their positions, and 25 closing their positions.
451% more call options, than puts
Call options by funds: $4.59M | Put options by funds: $832K
80% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 25
23% more repeat investments, than reductions
Existing positions increased: 138 | Existing positions reduced: 112
20% more capital invested
Capital invested by funds: $3.75B → $4.51B (+$761M)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
7.29% more ownership
Funds ownership: 123.65% → 130.94% (+7.3%)
5% more funds holding
Funds holding: 316 → 333 (+17)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$81.9M |
| 2 |
MSL
Mackay Shields LLC
New York
|
+$37.7M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
+$36M |
| 4 |
Millennium Management
New York
|
+$30.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$26.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$24.8M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$14.2M |
| 3 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$12.9M |
| 4 |
Two Sigma Investments
New York
|
-$12M |
| 5 |
RP
Reinhart Partners
Mequon,
Wisconsin
|
-$11.5M |
EHC Hedge Fund Activity: Q2 2017 in Review
333 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Encompass Health (EHC) for Q2 2017, worth a combined $4.51B — up 20% from $3.75B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new EHC positions and 25 closed out — a net gain of 20 holders — while 138 added to existing stakes and 112 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $81.9M. The largest seller was Renaissance Technologies, cutting an estimated $24.8M.
- 333 institutional investors held Encompass Health (EHC) as of Q2 2017, up from 316 in Q1 2017.
- Funds reported $4.51B of Encompass Health stock for Q2 2017, up 20% quarter-over-quarter.
- 45 funds opened new Encompass Health positions in Q2 2017 and 25 closed out, a net change of +20 holders.
- The largest Encompass Health buyer in Q2 2017 was Fidelity Investments, an estimated $81.9M added.
- The largest Encompass Health seller in Q2 2017 was Renaissance Technologies, an estimated $24.8M sold.
Based on aggregated 13F filings for Q2 2017.